Instituto de Investigación Sanitaria Galicia Sur (IISGS)
Centro de investigación
Icahn School of Medicine at Mount Sinai
Nueva York, Estados UnidosPublicacións en colaboración con investigadores/as de Icahn School of Medicine at Mount Sinai (38)
2024
-
Cross-Validation of Risk Scores for Patients Undergoing Transcatheter Edge-to-Edge Repair for Mitral Regurgitation
Journal of the Society for Cardiovascular Angiography and Interventions, Vol. 3, Núm. 2
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants
Nature Genetics, Vol. 55, Núm. 12, pp. 2065-2074
-
Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry
American Journal of Human Genetics, Vol. 110, Núm. 7, pp. 1200-1206
-
Transaxillary versus transfemoral access as default access in TAVI: A propensity matched analysis
International Journal of Cardiology
2022
-
International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis
JAMA Dermatology, Vol. 158, Núm. 5, pp. 561-572
-
Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score
Prostate cancer and prostatic diseases, Vol. 25, Núm. 4, pp. 755-761
-
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)
European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301
2021
-
Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent
Catheterization and Cardiovascular Interventions, Vol. 98, Núm. 3, pp. 503-510
-
Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes
Journal of the American College of Cardiology, Vol. 77, Núm. 22, pp. 2777-2791
-
Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways
Advances in Therapy
-
One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration
Cardiovascular Drugs and Therapy, Vol. 35, Núm. 2, pp. 309-320
-
Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (Nature Genetics, (2021), 53, 1, (65-75), 10.1038/s41588-020-00748-0)
Nature Genetics
-
Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration
Catheterization and Cardiovascular Interventions, Vol. 97, Núm. 5, pp. 797-804
-
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
Nature Genetics, Vol. 53, Núm. 1, pp. 65-75
-
Triglycerides and Residual Atherosclerotic Risk
Journal of the American College of Cardiology, Vol. 77, Núm. 24, pp. 3031-3041
2020
-
1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registry
IJC Heart and Vasculature, Vol. 31
-
1-Year Outcomes with COMBO Stents in Small-Vessel Coronary Disease: Subgroup Analysis From the COMBO Collaboration
Cardiovascular Revascularization Medicine, Vol. 21, Núm. 12, pp. 1542-1547
-
1-year results after PCI with the COMBO stent in all-comers in Asia versus Europe: Geographical insights from the COMBO collaboration
International Journal of Cardiology, Vol. 307, pp. 17-23
-
Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry)
American Journal of Cardiology, Vol. 127, pp. 1-8